YouTube.com
Sep 9, 2024, 10:07
Nelson Dusetti: Grateful to Institut National Du Cancer for funding through the PRT-K 2024 program
Nelson Dusetti shared on X:
“Grateful to Institut National Du Cancer for funding through the PRT-K 2024 program!
This support helps us study treatment resistance in pancreatic cancer, strengthening the collaboration between CRCM – Cancer Research Centre of Marseille and Paoli-Calmettes Institute.”
Additional information.
Source: Nelson Dusetti/X
Nelson Dusetii is the Scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM. He is also research director at INSERM. He is the Head of the Department of Translational Research and Innovative Therapies at CRCM.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14